Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene |
| |
Authors: | Christian Balmer Diana Ballhausen Nils U. Bosshard Beat Steinmann Eugen Boltshauser Urs Bauersfeld Andrea Superti-Furga |
| |
Affiliation: | (1) Department of Paediatric Cardiology, University Childrens Hospital, Steinwiesstrasse 75, 8032 Zurich, Switzerland;(2) Division of Metabolism and Molecular Paediatrics, University Childrens Hospital, Zurich, Switzerland;(3) Division of Neurology, University Childrens Hospital, Zurich, Switzerland;(4) Division of Molecular Paediatrics, University Hospital Lausanne (CHUV), Lausanne, Switzerland |
| |
Abstract: | A boy presented at age 2.5 years with mild left ventricular hypertrophy and mild myopathy. Hypertrophic cardiomyopathy progressed relentlessly, leading to death at age 16 years shortly before planned heart transplantation. During the course of the disease, his mother developed severe dilated cardiomyopathy and died of its complications at 46 years of age. The combination of myopathy and cardiomyopathy, the biochemical and electron microscopy findings in a muscle biopsy, and the pedigree suggested Danon disease (MIM 300257), an X-linked lysosomal storage disorder caused by deficiency of lysosome-associated membrane protein-2 (LAMP2). The diagnosis was confirmed by the identification of a novel mutation, G138A, in the LAMP2gene, leading to the premature stop codon W46X. Conclusion:Early diagnosis of Danon disease is important for genetic counselling and timely cardiac transplantation, the only effective therapeutic option. |
| |
Keywords: | Danon disease Glycogen storage disease with normal acid maltase LAMP2 deficiency Lysosomal membrane X-linked vacuolar cardiomyopathy and myopathy |
本文献已被 PubMed SpringerLink 等数据库收录! |
|